Commentary: simvastatin as the key to improving H. pylori eradication rates?

被引：4

作者：

den Hollander, W. J. ^{[1
]}

Kuipers, E. J. ^{[1
,2
]}

机构：

[1] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands

[2] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2012年 / 36卷 / 05期

关键词：

D O I：

10.1111/j.1365-2036.2012.05195.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

页码：493 / 493

页数：1

共 5 条

[1]

Chemoprevention for gastric cancer [J].

Ford, Alexander C. .

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2011, 25 (4-5) :581-592

[2]

Helicobacter pylori treatment in the era of increasing antibiotic resistance [J].

Graham, David Y. ;

Fischbach, Lori .

GUT, 2010, 59 (08) :1143-1153

[3]

Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus [J].

Kastelein, Florine ;

Spaander, Manon C. W. ;

Biermann, Katharina ;

Steyerberg, Ewout W. ;

Kuipers, Ernst J. ;

Bruno, Marco J. .

GASTROENTEROLOGY, 2011, 141 (06) :2000-2008

[4]

Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report [J].

Malfertheiner, Peter ;

Megraud, Francis ;

O'Morain, Colm A. ;

Atherton, John ;

Axon, Anthony T. R. ;

Bazzoli, Franco ;

Gensini, Gian Franco ;

Gisbert, Javier P. ;

Graham, David Y. ;

Rokkas, Theodore ;

El-Omar, Emad M. ;

Kuipers, Ernst J. .

GUT, 2012, 61 (05) :646-664

[5]

Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate - a placebo-controlled study [J].

Nseir, W. ;

Diab, H. ;

Mahamid, M. ;

Abu-Elheja, O. ;

Samara, M. ;

Abid, A. ;

Mograbi, J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (03) :231-238

← 1 →